By Dan Prochilo ( January 9, 2014, 10:02 PM EST) -- The deceit Cephalon Inc. researcher and attorney allegedly used to obtain a patent for the drug Provigil didn't exempt communications between the drugmaker and its lawyers from attorney-client privilege, a Pennsylvania federal judge ruled Thursday, denying a motion in a pay-for-delay class action....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.